Cancer Therapeutics and Nanotherapies sign letter of intent (News-Medical-Net)

Cancer Therapeutics, Inc. (OTCBB: CTHP), an emerging biotechnology business incubator with a specific emphasis on disruptive cancer treatments and nanotechnology, announced today it has signed a letter of intent to acquire another 26 percent interest in NanoTherapies, LLC which would give Cancer Therapeutics a total of 51 percent and controlling interest of NanoTherapies.
(get the story…)

Related items

• Cancer Therapeutics Announces Letter of Intent With NanoTherapies, LLC (Marketwire via Yahoo! Finance)
• How Tiny Nanoparticles Are Transforming Technology (NPR)
• Cancer Therapeutics Signs Letter of Intent to Purchase Stake in NanoTherapies, LLC. (Marketwire via Yahoo! Finance)
• Cancer Therapeutics, Inc. Announces New Direction; Launches New Web Site — www.cancer-therapeutics.com (Marketwire)
• Cancer Therapeutics, Inc. Announces New Direction; Launches New Web Site — www.cancer-therapeutics.com (Marketwire via Yahoo! Finance)

Tags: and nanotechnology, biotechnology business, business incubator, cancer, cancer therapeutics, cancer treatment, cancer treatments, interest, nano, nanoparticle, nanoparticles, nanotech, nanotechnology, NanoTherapies, percent, Technology, Therapeutics, therapeutics inc

This entry was posted on Monday, October 19th, 2009 at 9:50 am and is filed under Technology.